University of California San Francisco
Give to UCSF
A future in which precision medicine benefits everyone is not guaranteed. For that to happen, UCSF experts argue, the health care industry must first tackle today’s health disparities, including differences in disease outcomes and access to care based on race, gender, and socioeconomic status.
With the rise of “direct-to-consumer” DNA tests, investigating your genes is easier than ever. But taking one of these tests may not be right for you, says UCSF professor Kathryn Phillips, PhD, who studies new health care technologies.
Browse the stories that most engaged our readers in 2019.
UCSF physician Peter Ganz and colleagues at Colorado-based SomaLogic Inc., are developing what they call “liquid health check” technology – a single blood test capable of painting a detailed portrait of a person’s current health and future disease risks.
Three in four patients with anorexia nervosa make a partial recovery. But just 21 percent make a full recovery, a milestone that is most likely to signal permanent remission.
The Kidney Project team reported that UCSF scientists successfully implanted a prototype kidney bioreactor containing functional human kidney cells in large animals without significant safety concerns.
Adolescents and young adults with anorexia nervosa whose weight is in the healthy, overweight or obese ranges face similar cardiovascular and other health complications as their counterparts with low BMI.
In what is believed to be one of the first analyses of frequent emergency department users to include integrated medical, behavioral and social service data, a new UCSF study comprehensively examined these patients’ use of both medical and nonmedical services.
